Hemostasis instrument

US10335223B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10335223-B2
Application numberUS-201113881269-A
CountryUS
Kind codeB2
Filing dateOct 24, 2011
Priority dateOct 26, 2010
Publication dateJul 2, 2019
Grant dateJul 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A hemostasis instrument for actively stopping the bleeding, in particular after an open, laparoscopic, or endoscopic operation on a patient, having several hemostasis components. The hemostasis instrument has at least the following hemostasis components: a thermal hemostasis device for tissue coagulation by producing a temperature above the coagulation temperature of biological tissue by means of a coagulation electrode; a biochemical hemostasis device for producing a silent electric discharge by means of at least one discharge electrode, and an insulating device, wherein the insulating device is arranged between the discharge electrode and the tissue to be treated; a supplying device for supplying substances that influence blood clotting to the tissue to be treated; and a supply device for supplying noble gas to the tissue to be treated.

First claim

Opening claim text (preview).

The invention claimed is: 1. A hemostasis instrument for actively stopping bleeding comprising a plurality of hemostasis components, wherein at least the following hemostasis components are provided: a thermal hemostasis apparatus for tissue coagulation by generating a temperature above the coagulation temperature of biological tissue by a coagulation electrode, the thermal hemostasis apparatus including a lumen and a channel extending within the lumen and beyond a terminal face of the lumen, wherein the coagulation electrode is axially movable within the channel; a biochemical hemostasis apparatus for generating a dielectric barrier discharge which does not heat the biological tissue by an amount sufficient to raise the temperature of the biological tissue to the coagulation temperature of the biological tissue; the biochemical hemostasis apparatus comprising at least one discharge electrode and an elastic insulation apparatus, wherein the elastic insulation apparatus is disposed at a distal end of the channel in spaced relation with a distal end of the lumen and the elastic insulation apparatus is adapted to be arranged between the at least one discharge electrode and a tissue to be treated, and wherein the coagulation electrode of the thermal hemostasis apparatus at the same time forms the discharge electrode of the biochemical hemostasis apparatus and the at least one discharge electrode is capable of penetrating through the elastic insulation apparatus; a supply apparatus for supplying substances influencing blood clotting to the tissue to be treated, and a supply apparatus for supplying noble gas to the tissue to be treated. 2. The hemostasis instrument of claim 1 , wherein the hemostasis instrument comprises a further hemostasis component in a form of a thermal hemostasis apparatus for endogenous or exogenous heating of the blood during a dielectric barrier discharge to a temperature below a coagulation temperature of biological tissue. 3. The hemostasis instrument of claim 1 , wherein the thermal hemostasis apparatus is designed for contact coagulation or for plasma coagulation. 4. The hemostasis instrument of claim 1 , wherein the hemostasis instrument comprises at least one tissue sensor which is adapted to capture tissue effects generated during use of one or more hemostasis components. 5. The hemostasis instrument of claim 1 , wherein an optimum setting of the hemostasis instrument depends on situation- and patient-dependent influences. 6. The hemostasis instrument of claim 5 , wherein the patient-dependent influences are available in the form of patient information captured by at least one biosensor. 7. A surgical apparatus for stopping bleeding comprising: at least one biosensor for capturing blood properties of a patient during, before, or at the start of a surgical intervention; a hemostasis instrument with a plurality of hemostasis components comprising at least one thermal hemostasis component and one biochemical hemostasis component, the thermal hemostasis component including a lumen and a channel extending within the lumen and beyond a terminal face of the lumen, the biochemical hemostasis component comprising at least one discharge electrode and an insulation apparatus, wherein the insulation apparatus is disposed at a distal end of the channel in spaced relation with a distal end of the lumen and the elastic insulation apparatus is adapted to be arranged between the discharge electrode and the tissue to be treated and the discharge electrode is fed with RF-current, wherein a coagulation electrode of the thermal hemostasis apparatus at the same time forms the discharge electrode of the biochemical hemostasis apparatus, and wherein the coagulation electrode is axially movable within the channel, wherein the at least one discharge electrode is capable of penetrating through the insulation apparatus, and wherein an optimum setting of the hemostasis instrument depends on the blood properties of the patient captured by the at least one biosensor, wherein the biochemical hemostasis component is designed to generate a dielectric barrier discharge which does not heat the tissue by an amount sufficient to raise the temperature of the biological tissue to the coagulation temperature of the biological tissue. 8. The surgical apparatus of claim 7 , wherein the thermal hemostasis component is designed for tissue coagulation by generating a temperature above the coagulation temperature of biological tissue by a coagulation electrode, which is fed with RF-current. 9. The surgical apparatus of claim 8 , wherein the thermal hemostasis component is designed for contact coagulation or for plasma coagulation. 10. The surgical apparatus of claim 7 , further comprising a hemostasis component in a form of a supply apparatus for supplying substances influencing blood clotting to a tissue to be treated. 11. The surgical apparatus of claim 7 , further comprising a hemostasis component in a form of a supply apparatus for supplying noble gas to a tissue to be treated. 12. The surgical apparatus of claim 7 , further comprising a hemostasis component in a form of a thermal hemostasis apparatus for endogenous or exogenous heating of the blood during a dielectric barrier discharge to a temperature below a coagulation temperature of biological tissue. 13. The surgical apparatus of claim 7 , wherein the surgical apparatus comprises a tissue sensor which is adapted to capture tissue effects generated during the use of one or more hemostasis components. 14. The surgical apparatus of claim 12 , wherein the surgical apparatus is configured in such a way that the setting of the hemostasis instrument can be optimized based on captured values of a tissue sensor and of the biosensor in “real-time” by a control unit provided in the surgical apparatus. 15. The hemostasis instrument of claim 1 , wherein the substances influencing blood clotting comprise fibrinogen, thrombin, aprotinin, blood clotting factors or a combination thereof. 16. The surgical apparatus of claim 10 , wherein the substances influencing blood clotting comprise fibrinogen, thrombin, aprotinin, blood clotting factors, or a combination thereof. 17. The hemostasis instrument of claim 3 , wherein the plasma coagulation is argon plasma coagulation. 18. A hemostasis instrument for actively stopping bleeding comprising a plurality of hemostasis components, wherein at least the following hemostasis components are provided: a thermal hemostasis apparatus for tissue coagulation by generating a temperature above the coagulation temperature of biological tissue by a coagulation electrode, the thermal hemostasis apparatus including a lumen and a channel extending within the lumen and beyond a terminal face of the lumen, wherein the coagulation electrode is axially movable within the channel; a biochemical hemostasis apparatus for generating a dielectric barrier discharge which does not heat the biological tissue by an amount sufficient to raise the temperature of the biological tissue to the coagulation temperature of the biological tissue; the biochemical hemostasis apparatus comprising at least one discharge electrode and an insulation apparatus, wherein the insulation apparatus is disposed at a distal end of the channel in spaced relation with a distal end of the lumen and the elastic insulation apparatus is adapted to be arranged between the at least one discharge electrode and a tissue to be treated, and wherein the coagulation electrode of the thermal hemostasis apparatus at the same time forms the discharge electrode o

Assignees

Inventors

Classifications

  • combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound · CPC title

  • Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue · CPC title

  • Coagulation · CPC title

  • Female reproductive organs · CPC title

  • using additional gas becoming plasma · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10335223B2 cover?
A hemostasis instrument for actively stopping the bleeding, in particular after an open, laparoscopic, or endoscopic operation on a patient, having several hemostasis components. The hemostasis instrument has at least the following hemostasis components: a thermal hemostasis device for tissue coagulation by producing a temperature above the coagulation temperature of biological tissue by means …
Who is the assignee on this patent?
Neugebauer Alexander, Fischer Klaus, Enderle Markus D, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61B18/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).